| Closed |
SWOG-9240 |
A Phase II Trial of CVAD for Treatment of Non-Hodgkin's Lymphoma |
1/15/1993 |
2/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9504 |
A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer |
10/15/1996 |
12/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-8828 |
A Phase II Trial of Carboplatin (CBDCA) in Relapsed or Refractory Acute Myeloid Leukemia |
11/15/1989 |
10/15/1992 |
82% |
|
Published
|
| Closed |
S9629 |
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer |
5/15/1997 |
3/15/1999 |
100% |
|
Published
|
| Closed |
SWOG-9511 |
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach |
1/15/1997 |
11/15/1998 |
100% |
|
Published
|
| Closed |
SWOG-8744 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma |
8/1/1988 |
11/15/1990 |
27% |
|
|
| Closed |
SWOG-8741 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast |
9/15/1988 |
11/15/1990 |
63% |
|
Published
|
| Closed |
SWOG-8755 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma |
6/15/1988 |
1/1/1990 |
|
|
Published
|
| Closed |
SWOG-8743 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma |
6/15/1988 |
1/1/1990 |
71% |
|
Published
|
| Closed |
SWOG-8760 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma |
6/15/1988 |
1/1/1990 |
83% |
|
Published
|
| Closed |
SWOG-8808 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia |
11/15/1989 |
11/15/1990 |
0% |
|
|
| Closed |
SWOG-8806 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594) |
8/15/1988 |
11/15/1990 |
25% |
|
|
| Closed |
SWOG-8752 |
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer |
9/15/1988 |
7/15/1990 |
17% |
|
|
| Closed |
SWOG-8735 |
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia |
4/1/1988 |
5/15/1990 |
57% |
|
|
| Closed |
S9711 |
A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia. |
5/15/1997 |
8/15/1998 |
10% |
|
|
| Closed |
SWOG-8832 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer |
4/1/1989 |
11/15/1990 |
6% |
|
|
| Closed |
SWOG-8830 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer |
4/1/1989 |
11/15/1990 |
10% |
|
|
| Closed |
SWOG-8824 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma |
5/1/1989 |
8/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-8822 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma |
5/1/1989 |
6/15/1991 |
6% |
|
|
| Closed |
SWOG-9148 |
A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non… |
9/1/1992 |
6/1/1995 |
58% |
|
|
